Sec Form 4 Filing - HALVORSON ERIC H @ PHARMACYCLICS INC - 2014-03-04

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person HALVORSON ERIC H 2. Issuer Name and Ticker or Trading Symbol PHARMACYCLICS INC [ PCYC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O PHARMACYCLICS, INC., 995 EAST ARQUES AVENUE 3. Date of Earliest Transaction (MM/DD/YY) 03/04/2014 (Street) SUNNYVALE, CA94085 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/04/2014 M 2,500 A $ 14.26 3,500 D Common Stock 03/04/2014 M 148 A $ 15.02 3,648 D Common Stock 03/04/2014 M 824 A $ 28.47 4,472 D Common Stock 03/04/2014 S 3,472 D $ 138.33 1,000 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 14.26 03/04/2014 M 2,500 12/15/2011( 1 ) 12/15/2021 Common Stock 2,500 $ 0 12,500 D Stock Option (Right to Buy) $ 15.02 03/04/2014 M 148 01/03/2012( 2 ) 01/03/2022 Common Stock 148 $ 0 0 D Stock Option (Right to Buy) $ 28.47 03/04/2014 M 824 04/02/2012( 2 ) 04/02/2022 Common Stock 824 $ 0 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other HALVORSON ERIC H C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE, CA94085 X Signatures /s/ Eric Halvorson 03/06/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Immediately exercisable option granted to Reporting Person pursuant to issuer's 2004 Equity Incentive Award Plan in a transaction exempt under Rule 16b-3(d). The shares are subject to repurchase upon optionee's termination of service prior to vesting of such shares. The repurchase right lapses in equal and succesive annual installments for the five (5) years following 12/15/2011. ( 2 )Represents grant of fully-vested option pursuant to Issuer's 2004 Equity Incentive Award Plan in lieu of payment of quarterly retainer and/or meeting fees earned for service on Issuer's Board of Directors

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.